Globus Medical Inc
GMEDNYSECIK 1237831HealthcareFiscal year ends Dec 31
Reports and events: 211 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0617:06 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-054450 |
| 2026-08-0616:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-054353 |
| 2026-06-0416:11 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-26-040784 |
| 2026-05-0717:03 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628280-26-032290 |
| 2026-05-0716:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-032164 |
| 2026-04-2416:04 ET | DEF 14A | Proxy statementPeriod 2026-06-03 | 0001628280-26-027196 |
| 2026-03-2317:26 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-020612 |
| 2026-02-2417:08 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001628280-26-011209 |
| 2026-02-2416:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-011124 |
| 2026-01-0716:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-001189 |
| 2025-11-0617:10 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001237831-25-000031 |
| 2025-11-0616:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001237831-25-000029 |
| 2025-08-0717:05 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001562762-25-000200 |
| 2025-08-0716:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-25-000198 |
| 2025-07-2108:05 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001562762-25-000166 |
| 2025-06-0516:45 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001562762-25-000158 |
| 2025-05-1516:41 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001562762-25-000131 |
| 2025-05-0817:19 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001562762-25-000118 |
| 2025-05-0816:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-25-000114 |
| 2025-04-2516:20 ET | DEF 14A | Proxy statementPeriod 2025-06-04 | 0001562762-25-000092 |
| 2025-04-0309:00 ET | 8-K | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-071923 |
| 2025-02-2017:05 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001562762-25-000026 |
| 2025-02-2016:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-25-000024 |
| 2025-02-0616:54 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-021848 |
| 2025-01-0816:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-25-000006 |
| 2024-11-0517:05 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001562762-24-000254 |
| 2024-11-0516:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-24-000250 |
| 2024-08-1317:10 ET | 8-K | 8.01 Other events | 0001562762-24-000209 |
| 2024-08-0617:06 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001562762-24-000199 |
| 2024-08-0616:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-24-000195 |
| 2024-06-0616:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001562762-24-000163 |
| 2024-05-0717:05 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001562762-24-000126 |
| 2024-05-0716:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-24-000124 |
| 2024-04-2616:21 ET | DEF 14A | Proxy statementPeriod 2023-12-31 | 0001562762-24-000102 |
| 2024-02-2118:32 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001562762-24-000032 |
| 2024-02-2016:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-24-000030 |
| 2024-02-0516:45 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001562762-24-000019 |
| 2024-01-1016:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-24-000006 |
| 2023-11-1517:30 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001193125-23-278012 |
| 2023-11-0717:30 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001562762-23-000407 |
| 2023-11-0716:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-23-000405 |
| 2023-10-0216:25 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001562762-23-000357 |
| 2023-09-0111:06 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-227191 |
| 2023-08-0317:15 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001562762-23-000307 |
| 2023-08-0316:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-23-000305 |
| 2023-06-0816:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001562762-23-000269 |
| 2023-05-0417:15 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001562762-23-000210 |
| 2023-05-0416:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-23-000208 |
| 2023-05-0317:21 ET | 8-K | 8.01 Other events | 0001193125-23-134571 |
| 2023-04-2816:26 ET | DEF 14A | Proxy statement | 0001562762-23-000185 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 11:47 ET. Listed shows no prices and gives no investment advice.